Sarah James
Stock Analyst at Cantor Fitzgerald
(2.12)
# 2,703
Out of 4,826 analysts
279
Total ratings
32.56%
Success rate
-3.73%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Reiterates: Neutral | $290 | $256.69 | +12.98% | 21 | May 1, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $416.63 | +16.41% | 20 | Apr 23, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $333.46 | +9.46% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $26.32 | +10.18% | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $7.52 | +99.47% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $148.77 | +18.98% | 20 | Feb 13, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $405 | $349.43 | +15.90% | 19 | Jan 27, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $700 | $404.81 | +72.92% | 17 | Jan 17, 2025 | |
| CNC Centene | Reiterates: Overweight | $90 | $59.78 | +50.55% | 12 | Dec 11, 2024 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $22.81 | +127.97% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $17 | $23.40 | -27.35% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $178.19 | +22.90% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $406 | $319.63 | +27.02% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $23.49 | +83.06% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $4.06 | +294.09% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $67.10 | -7.60% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $2.35 | +113.22% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.15 | +39.86% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $96.19 | +5.00% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $141.26 | -5.85% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $15.18 | +176.68% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $2.97 | +68.35% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $4.73 | +5.82% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $15.48 | +35.66% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $53.11 | -26.57% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $66.58 | +189.88% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.86 | - | 2 | Mar 1, 2017 |
Humana
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $256.69
Upside: +12.98%
Elevance Health
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $416.63
Upside: +16.41%
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $333.46
Upside: +9.46%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $26.32
Upside: +10.18%
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $7.52
Upside: +99.47%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $148.77
Upside: +18.98%
HCA Healthcare
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $349.43
Upside: +15.90%
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $404.81
Upside: +72.92%
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $59.78
Upside: +50.55%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $22.81
Upside: +127.97%
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $23.40
Upside: -27.35%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $178.19
Upside: +22.90%
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $319.63
Upside: +27.02%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $23.49
Upside: +83.06%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $4.06
Upside: +294.09%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $67.10
Upside: -7.60%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $2.35
Upside: +113.22%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.15
Upside: +39.86%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $96.19
Upside: +5.00%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $141.26
Upside: -5.85%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $15.18
Upside: +176.68%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $2.97
Upside: +68.35%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $4.73
Upside: +5.82%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $15.48
Upside: +35.66%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $53.11
Upside: -26.57%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $66.58
Upside: +189.88%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.86
Upside: -